Corrigendum to: "Functional and Histological Changes after Myoblast Injections in the Porcine Rhabdosphincter" [Eur Urol 2007;52:1736-43].
作者信息
Mitterberger Michael, Pinggera Germar M, Marksteiner Rainer, Margreiter Eva, Plattner Raffael, Klima Günter, Strasser Hannes
机构信息
Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
出版信息
Eur Urol. 2008 Nov;54(5):1208. doi: 10.1016/j.eururo.2008.08.072. Epub 2008 Sep 4.
PMID:28042786
Abstract
摘要
相似文献
1
Corrigendum to: "Functional and Histological Changes after Myoblast Injections in the Porcine Rhabdosphincter" [Eur Urol 2007;52:1736-43].
Eur Urol. 2008 Nov;54(5):1208. doi: 10.1016/j.eururo.2008.08.072. Epub 2008 Sep 4.
2
Re: Michael Mittenberger, Germar M. Pinggera, Rainer Marksteiner, Eva Margreiter, Raffael Plattner, Günter Klima, Georg Bartsch and Hannes Strasser. Functional and histological changes after myoblast injections in the porcine rhabdosphincter. Eur urol 2007;52:1736-43.
Eur Urol. 2008 Jan;53(1):212-3; author reply 213-4. doi: 10.1016/j.eururo.2007.07.028. Epub 2007 Jul 23.
3
Functional and histological changes after myoblast injections in the porcine rhabdosphincter.
Eur Urol. 2007 Dec;52(6):1736-43. doi: 10.1016/j.eururo.2007.05.007. Epub 2007 May 22.
4
Corrigendum to "Re: Kari A.O. Tikkinen, Anssi Auvinen. Does the Imprecise Definition of Overactive Bladder Serve Commercial Rather than Patient Interests? Eur Urol 2012;61:746-8. The Origin of the Term Overactive Bladder, Industry, and Patient Care" [Eur Urol 2012;61:749-50].
Eur Urol. 2012 Aug;62(2):e48. doi: 10.1016/j.eururo.2012.05.019. Epub 2012 May 19.
5
Corrigendum to "Reply to Ruth E. Langley, Patricia Price and Paul D. Abel's Letter to the Editor re: Claude C. Schulman, Jacques Irani, Juan Morote, et al. Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review. Eur Urol Suppl 2010;9:675-91" [Eur Urol 2011;59:e26].
Eur Urol. 2011 Jul;60(1):194. doi: 10.1016/j.eururo.2011.03.032. Epub 2011 Mar 31.
6
Corrigendum re: "Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin" [Eur Urol 2016;69:197-200].
Eur Urol. 2016 Jul;70(1):e26. doi: 10.1016/j.eururo.2016.02.059. Epub 2016 Mar 4.
7
Corrigendum to "Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial" [Eur Urol 2013;64:703-9].
Eur Urol. 2015 Aug;68(2):e46. doi: 10.1016/j.eururo.2015.01.021. Epub 2015 Feb 4.
8
Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)].
Eur Urol. 2009 Apr;55(4):1000-1001. doi: 10.1016/j.eururo.2008.06.035. Epub 2008 Jun 20.
9
Corrigendum to "Profile of Silodosin" [Eur Urol Suppl 2010;9:491-5].
Eur Urol. 2011 Feb;59(2):315. doi: 10.1016/j.eururo.2010.11.014. Epub 2010 Nov 21.
10
Corrigendum to "The Epidemiology of Renal Cell Carcinoma" [Eur Urol 2011;60:615-21].
Eur Urol. 2011 Dec;60(6):1317. doi: 10.1016/j.eururo.2011.09.001. Epub 2011 Sep 13.
引用本文的文献
1
Establishing and monitoring of urethral sphincter deficiency in a large animal model.
World J Urol. 2017 Dec;35(12):1977-1986. doi: 10.1007/s00345-017-2088-3. Epub 2017 Sep 22.
Zotero 插件